Financing channel feed – Endpoints News

Financing channel feed

AbbVie, Sanofi-backed Principia offers an $86M IPO after burning through $148M for pipeline work

7 years ago

Dermatology biotech Blueberry Therapeutics banks $12M Series B — and new partners in Asia

7 years ago

Billionaire-backed Juvenescence spins out anti-aging, AI startup Napa Therapeutics

7 years ago

Fresh from hauling in GSK’s budget-priced gene therapy group, Orchard harvests $150M mega-round. Is it time to IPO?

7 years ago

Back to the beginning: Pfizer seeds discovery-stage neuro startup Magnolia (after axing its own brain R&D)

7 years ago

Pfizer, Novartis jump into an $84M development round for UK cancer drug stars at Artios

7 years ago

Touting its manufacturing strengths, Tot Biopharm raises $102M mega-round to ramp up cancer R&D

7 years ago

Tapping Chinese investors, Apexigen closes $73M for 8 trials in I/O

7 years ago

BeiGene takes a hit after historic $903M Hong Kong IPO with negative biotech sentiment

7 years ago

Third Rock's Ambys hauls $140M for liver disease, inking Takeda deal ahead of launch

7 years ago

Samsung outlines blockbuster investment plan for biopharmaceuticals, part of a $22B play on next-gen tech

7 years ago

Mining real world data for drug development insights, Woodford-backed AI firm seeks $77M London IPO

7 years ago

NEA, 5AM back a $50M play to steer gene therapies to the clinic at Akouos — the latest startup in hearing

7 years ago

What's bigger than a unicorn? Samumed stuns yet again as anti-aging pipeline draws $438M at $12B valuation

7 years ago

Lilly Asian Ventures backs Impact's PARP research again, chipping in for $30M Series C led by Decheng Capital

7 years ago

BeiGene bags a staggering $903M IPO on the HKEX — and still manages to spark some nervous fretting

7 years ago

Can two old drugs — including an Eli Lilly flop — make one good treatment for Alzheimer’s? Karuna has $42M to find out

7 years ago

Ascletis breaks into HKEX, briefly rising on hotly anticipated public debut of first biotech

7 years ago

ReViral gets a $55M booster shot of cash as it expands its development work on an RSV treatment

7 years ago

The Google of CRISPR tech? Tech legends Tim Cook and Jeff Huber back Mammoth Biosciences

7 years ago

Faster, cheaper DNA sequencing gets Omniome $60M led by Chinese investors

7 years ago

Fresh out of 6 Dimensions' incubator, Curon launches with $150M and backing from Boyu, Temasek

7 years ago

In for the China biotech gold rush, BeiGene eyes monster $800M-plus Hong Kong IPO

7 years ago

Days after Merck deal, Sutro rolls out $85M E round to fund internal cancer pipeline

7 years ago

First page Previous page 123 124 125126127 128 129 Next page Last page